Bio Essence Corp Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2021 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Bio Essence Corp quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2021 to Q2 2023.
  • Bio Essence Corp Deferred Income Tax Expense (Benefit) for the quarter ending June 30, 2023 was $3.2K, unchanged year-over-year.
  • Bio Essence Corp annual Deferred Income Tax Expense (Benefit) for 2022 was $3.3K, unchanged from 2021.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $3.2K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q2 2022 $3.2K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2021 $3.3K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.